Sort   by:  
 Page size 
UnknownPhase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors.
Not available
S-EPMC9398147 | biostudies-literature
UnknownThe National Lung Screening Trial: overview and study design.
Not available
S-EPMC3009383 | biostudies-literature
UnknownEftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.
Not available
S-EPMC9035501 | biostudies-literature
UnknownActivity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia.
Not available
S-EPMC10646782 | biostudies-literature
UnknownNonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate.
Not available
S-EPMC9662867 | biostudies-literature
UnknownBrain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy.
Not available
S-EPMC12661634 | biostudies-literature
UnknownABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies.
Not available
S-EPMC11375461 | biostudies-literature
UnknownColorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.
Not available
S-EPMC3641846 | biostudies-literature
UnknownMortality results from a randomized prostate-cancer screening trial.
Not available
S-EPMC2944770 | biostudies-literature
UnknownResults of the two incidence screenings in the National Lung Screening Trial.
Not available
S-EPMC4307922 | biostudies-literature
Sort   by:  
 Page size